Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2025 is 57.06% vs NA in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2025 is 41.58% vs NA in Mar 2024
Interest
YoY Growth in year ended Mar 2025 is -26.80% vs NA in Mar 2024
Profit After Tax
YoY Growth in year ended Mar 2025 is 42.24% vs NA in Mar 2024
Compare Profit and Loss Results of Medistep Health.
Figures in Cr
standalone - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
49.00
123.00
-74.00
-60.16%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
49.00
123.00
-74.00
-60.16%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
1.00
-1.00
-100.00%
Raw Materials Consumed
43.00
68.00
-25.00
-36.76%
Power & Fuel Cost
0.00
7.00
-7.00
-100.00%
Employee Cost
0.00
14.00
-14.00
-100.00%
Operating Expenses
0.00
10.00
-10.00
-100.00%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
0.00
7.00
-7.00
-100.00%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
0.00
0.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
44.00
116.00
-72.00
-62.07%
Operating Profit (PBDIT) excl Other Income
5.00
6.00
-1.00
-16.67%
Other Income
0.00
9.00
-9.00
-100.00%
Operating Profit (PBDIT)
5.00
15.00
-10.00
-66.67%
Interest
0.00
12.00
-12.00
-100.00%
Profit before Depriciation and Tax
5.00
3.00
2.00
66.67%
Depreciation
0.00
9.00
-9.00
-100.00%
Profit Before Taxation & Exceptional Items
5.00
-6.00
11.00
183.33%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
5.00
-6.00
11.00
183.33%
Provision for Tax
1.00
0.00
1.00
0%
Profit After Tax
4.00
-6.00
10.00
166.67%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
2.00
140.00
-138.00
-98.57%
Profit Available for appropriations
6.00
134.00
-128.00
-95.52%
Appropriations
6.00
134.00
-128.00
-95.52%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
4.01
-4.07
8.08
198.53%
Profit And Loss - Net Sales
Net Sales 49.65 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 57.06% vs NA in Mar 2024
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 5.61 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 41.58% vs NA in Mar 2024
Profit And Loss - Interest
Interest 0.04 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -26.80% vs NA in Mar 2024
Profit And Loss - Profit After Tax
Profit After Tax 4.14 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 42.24% vs NA in Mar 2024






